Cargando…

Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases

Patients with Chronic Inflammatory Rheumatic diseases (CIRD) are at increased risk of cardiovascular disease (CVD), ascribed not only to classical risk factors, but also to the presence of chronic systemic inflammatory response. Αtherosclerosis, the cornerstone of CVD, is known to be accelerated in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arida, Aikaterini, Protogerou, Athanasios D., Kitas, George D., Sfikakis, Petros P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073407/ https://www.ncbi.nlm.nih.gov/pubmed/29954107 http://dx.doi.org/10.3390/ijms19071890

Ejemplares similares

PCSK9/LDLR System and Rheumatoid Arthritis-Related Atherosclerosis
por: Arida, Aikaterini, et al.
Publicado: (2021)

The Additive Value of Femoral Ultrasound for Subclinical Atherosclerosis Assessment in a Single Center Cohort of 962 Adults, Including High Risk Patients with Rheumatoid Arthritis, Human Immunodeficiency Virus Infection and Type 2 Diabetes Mellitus
por: Protogerou, Athanasios D., et al.
Publicado: (2015)

Arrhythmogenic Inflammatory Cardiomyopathy in Autoimmune Rheumatic Diseases: A Challenge for Cardio-Rheumatology
por: Mavrogeni, Sophie I., et al.
Publicado: (2019)

Osteoprotegerin and MTHFR gene variations in rheumatoid arthritis: association with disease susceptibility and markers of subclinical atherosclerosis
por: Arida, Aikaterini, et al.
Publicado: (2022)

Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes
por: Kastritis, Efstathios, et al.
Publicado: (2020)

Cardiovascular Magnetic Resonance Reveals Cardiac Pathophysiology in Autoimmune Rheumatic Diseases
por: Markousis-Mavrogenis, George, et al.
Publicado: (2021)

Arterial hypertension assessed “out-of-office” in a contemporary cohort of rheumatoid arthritis patients free of cardiovascular disease is characterized by high prevalence, low awareness, poor control and increased vascular damage-associated “white coat” phenomenon
por: Protogerou, Athanase D, et al.
Publicado: (2013)

The Platelet-to-Lymphocyte Ratio as an Inflammatory Marker in Rheumatic Diseases
por: Gasparyan, Armen Yuri, et al.
Publicado: (2019)

The role of inflammation, the autonomic nervous system and classical cardiovascular disease risk factors on subendocardial viability ratio in patients with RA: a cross-sectional and longitudinal study
por: Sandoo, Aamer, et al.
Publicado: (2012)

A Powerful Paradigm for Cardiovascular Risk Stratification Using Multiclass, Multi-Label, and Ensemble-Based Machine Learning Paradigms: A Narrative Review
por: Suri, Jasjit S., et al.
Publicado: (2022)

Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases
por: Fragoulis, George E, et al.
Publicado: (2022)

Ventricular Tachycardia Has Mainly Non-Ischaemic Substrates in Patients with Autoimmune Rheumatic Diseases and a Preserved Ejection Fraction
por: Markousis-Mavrogenis, George, et al.
Publicado: (2021)

Nocebo-Prone Behaviour in Patients with Autoimmune Rheumatic Diseases during the COVID-19 Pandemic
por: Fragoulis, George E., et al.
Publicado: (2020)

Carotid intima-media thickness and endothelial function: useful surrogate markers for establishing cardiovascular risk in patients with inflammatory rheumatic disease – authors' response
por: van Zanten, Jet JCS Veldhuijzen, et al.
Publicado: (2008)

Different systemic rheumatic diseases as risk factors for COVID-19-related mortality
por: Fragoulis, George E., et al.
Publicado: (2022)

Does Sodium Intake Induce Systemic Inflammatory Response? A Systematic Review and Meta-Analysis of Randomized Studies in Humans
por: Basdeki, Eirini D., et al.
Publicado: (2021)

The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis
por: Arida, Aikaterini, et al.
Publicado: (2010)

Postchikungunya Chronic Inflammatory Rheumatism
por: Sacco, Keith A., et al.
Publicado: (2016)

COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments
por: Ouédraogo, Dieu-Donné, et al.
Publicado: (2020)

The role of the Nocebo effect in the use of biosimilars in routine rheumatology clinical practice
por: Kravvariti, Evrydiki, et al.
Publicado: (2019)

Alterations in Retinal Vessel Diameters in Patients with Retinal Vein Occlusion before and after Treatment with Intravitreal Ranibizumab
por: Aissopou, Evaggelia, et al.
Publicado: (2023)

Increased influenza vaccination rates in patients with autoimmune rheumatic diseases during the Covid-19 pandemic: a cross-sectional study
por: Fragoulis, George E., et al.
Publicado: (2021)

Signal Transduction Pathways in Chronic Inflammatory Rheumatic Diseases
por: Cope, Andrew P
Publicado: (2012)

Asymmetric Dimethylarginine as a Surrogate Marker of Endothelial Dysfunction and Cardiovascular Risk in Patients with Systemic Rheumatic Diseases
por: Dimitroulas, Theodoros, et al.
Publicado: (2012)

Immunomics in inflammatory rheumatic diseases
por: Konthur, Z, et al.
Publicado: (2004)

Is Acute Rheumatism an Inflammatory Disease?
por: Craig, T. E.
Publicado: (1889)

Dysfunctional high-density lipoprotein in chronic inflammatory rheumatic diseases
por: Waldecker-Gall, Sabina, et al.
Publicado: (2023)

Arterial Distensibility in Chronic Inflammatory Rheumatic Disorders
por: Yildiz, Mustafa
Publicado: (2010)

Introduction and switching of biologic agents are associated with antidepressant and anxiolytic medication use: data on 42 815 real-world patients with inflammatory rheumatic disease
por: Bournia, Vasiliki-Kalliopi, et al.
Publicado: (2020)

Control of Inflammatory Responses: a New Paradigm for the Treatment of Chronic Neuronal Diseases
por: Woo, Joo Hong, et al.
Publicado: (2015)

The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era
por: Evangelatos, Gerasimos, et al.
Publicado: (2022)

Predictors of new atherosclerotic carotid plaque development in patients with rheumatoid arthritis: a longitudinal study
por: Zampeli, Evangelia, et al.
Publicado: (2012)

Combined Effects of Diet and Physical Activity on Inflammatory Joint Disease: A Systematic Review and Meta-Analysis
por: Dinas, Petros C., et al.
Publicado: (2023)

Generic and disease-adapted cardiovascular risk scores as predictors of atherosclerosis progression in SLE
por: Panopoulos, Stylianos, et al.
Publicado: (2023)

Outcome measures in inflammatory rheumatic diseases
por: Fransen, Jaap, et al.
Publicado: (2009)

Vaccinations in autoimmune inflammatory rheumatic diseases
por: Szenborn, Leszek
Publicado: (2016)

Treatment of Inflammatory Rheumatism
por: Gibbs, O. C.
Publicado: (1854)

Effect of Biologics on Cardiovascular Inflammation: Mechanistic Insights and Risk Reduction
por: Fragoulis, George E, et al.
Publicado: (2021)

Editorial: Chronic rheumatic inflammatory conditions and cardiovascular health
por: Lo Gullo, Alberto, et al.
Publicado: (2022)

All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015–2019
por: Bournia, Vasiliki-Kalliopi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ic75bofm2dsos01cndho2enmba